OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480 | -12.7% | 38,846 | -36.2% | 0.00% | – |
| Q2 2023 | $550 | +170.9% | 60,853 | +4.4% | 0.00% | – |
| Q1 2023 | $203 | +20.8% | 58,300 | -14.9% | 0.00% | – |
| Q4 2022 | $168 | -99.9% | 68,500 | 0.0% | 0.00% | – |
| Q3 2022 | $190,000 | -31.9% | 68,500 | 0.0% | 0.00% | – |
| Q2 2022 | $279,000 | -7.6% | 68,500 | -3.3% | 0.00% | – |
| Q1 2022 | $302,000 | -54.0% | 70,872 | +1.0% | 0.00% | – |
| Q4 2021 | $657,000 | +172.6% | 70,172 | +713.8% | 0.00% | – |
| Q2 2021 | $241,000 | -13.9% | 8,623 | +2.0% | 0.00% | – |
| Q1 2021 | $280,000 | – | 8,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |